Can Corrected Transposition of the Great Arteries (CTGA) be cured?

Aug 18, 2026 Source: Cainiu Health
Dr. Tian Hongbo
Introduction
Corrective surgery for congenitally corrected transposition of the great arteries (ccTGA) cannot achieve a complete anatomical cure. This is a complex congenital cardiac structural anomaly characterized by a permanent discordant connection between the atria, ventricles, and great arteries. Surgical intervention can redirect blood flow and improve cardiac function, but it cannot fully restore the native cardiac anatomy. If symptoms such as palpitations, shortness of breath, or fatigue occur, prompt medical evaluation and treatment are essential.

Corrective surgery for congenitally corrected transposition of the great arteries (ccTGA) cannot achieve a complete anatomical cure. This is a complex congenital cardiac structural anomaly characterized by a permanent discordance between the atrioventricular connections and the great arteries. Surgical intervention can redirect blood flow and improve cardiac function, but it cannot fully restore the native cardiac anatomy. Patients experiencing symptoms such as palpitations, shortness of breath, or fatigue should seek prompt medical evaluation and treatment.

In patients with ccTGA, there is an inherent congenital anatomical abnormality: the right ventricle—normally responsible for pumping blood to the lungs—must sustain systemic circulation over the long term. This imposes chronic excessive workload on the myocardium, predisposing patients to arrhythmias and heart failure. Clinically, surgical approaches such as the double-switch procedure can redirect blood flow and repair associated cardiac defects. Combined with pharmacotherapy—including heart failure– and arrhythmia–targeted medications—these interventions help preserve cardiac function and effectively delay disease progression, thereby improving patients’ quality of life.

Following standardized surgical treatment, most patients achieve near-normal cardiac hemodynamics, with marked improvement in daily functional capacity. However, the underlying anatomical discordance persists, carrying long-term risks of progressive ventricular dysfunction and valvular disease. Therefore, lifelong clinical follow-up and monitoring are essential; therapeutic strategies must be adjusted dynamically according to changes in cardiac function to mitigate the risk of ongoing disease progression.

Patients should avoid strenuous physical activity and heavy labor, maintain regular sleep-wake cycles and emotional stability, strictly limit dietary sodium intake, and thereby reduce circulatory burden on the heart—ensuring long-term maintenance of stable cardiac function.